ArticleOpen forum infectious diseases2026
Tongue Swab Xpert MTB/RIF Ultra Testing for Tuberculosis in Adolescents: A Cross-sectional Study of Diagnostic Accuracy and Acceptability.
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Improved diagnostics are needed for tuberculosis (TB) among adolescents. Tongue swab (TS) molecular testing is a promising strategy for TB testing. We evaluated diagnostic accuracy and acceptability of Xpert MTB/RIF Ultra ("Xpert") using TSs for TB detection in adolescents. Methods: We conducted a cross-sectional diagnostic accuracy study in southern Vietnam. Adolescents aged 10-19 years who were recommended to undergo investigation for TB were eligible. Participants provided TS and sputum samples and were surveyed regarding sampling experiences. TS samples were tested on Xpert, with sputum tested on Xpert and liquid culture. We utilized a composite reference standard of a positive sputum Xpert or culture result to define disease status. Sensitivity, specificity, and diagnostic yield were calculated for TS Xpert. Results: From July to December 2025, we enrolled 225 adolescents. Most participants (157/225 [70%]) were close contacts of a person recently diagnosed with TB and many (129/225 [57%]) did not exhibit symptoms of presumptive TB. All adolescents could provide a TS, while 116 (52%) could produce mucopurulent sputum. Tuberculosis prevalence was relatively low (12/225 [5.3%]). TS Xpert sensitivity and specificity were 58.3% (90% confidence interval [CI], 35.6%-78.0%) and 99.5% (90% CI, 97.9%-99.9%), respectively. TS diagnostic yield among all diagnosed was 58.3% (7/12). TS sampling was highly acceptable to adolescents; the quickness and simplicity of collecting TSs were considered favorably. Conclusions: TS Xpert sensitivity and diagnostic yield were relatively low among adolescents recommended for TB investigation. All participants were able to provide a TS. Specificity was excellent. TS's high acceptability indicates it remains a promising sample for diagnostic algorithms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.